The Heron Therapeutics Inc. (HRTX) Stock Rating Reaffirm by the JMP Securities
The biotechnology company reported ($1.24) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($1.17)Â …
The biotechnology company reported ($1.24) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($1.17)Â …